… Lacosamide is generally effective and safe to use in children with epilepsy. … We aimed
to evaluate evidence for the efficacy and safety of LCM in pediatric patients with epilepsy. …

… Furthermore, this study demonstrated the effectiveness, safety, and tolerability profile of
early adjunctive lacosamide when added to one AED in the elderly population. …

… Lacosamide seems to be effective and safe according to the data in our small cohort.
Further prospective studies on lacosamide efficacy and safety in a large number of children are …

… epilepsy. We aimed to provide more conclusive evidence for the safety and tolerability of LCM
in patients with epilepsy. … : Lacosamide is generally safe and well tolerated in patients with …

… (200–600 mg/day) for 2 days, according to a multinational, phase II study primarily designed
to evaluate the safety of intravenous lacosamide [21]. The pattern and daily frequency of …

… a history of receiving epilepsy treatment before being switched to lacosamide. Thus, the
likelihood that poor outcomes would be associated with diagnostic delay in our patients is low. …

… Epilepsy management in elderly patients is often complex … used in elderly patients with
epilepsy while lacosamide (LCM), … in elderly patients affected by focal onset epilepsy compared …

… (30- and 60-minute infusion) as replacement for oral lacosamide showed that the safety and
… safety of lacosamide when administered concomitantly with up to three AEDs in patients …

… Lacosamide (LCM) was approved in China in 2018. However, the safety of LCM has not
been established in pediatric patients. … its safety, efficacy, and tolerability in pediatric patients …

… was to review our centre's experience with lacosamide and to characterize its … lacosamide
appears to be a safe and effective adjunctive therapy for children with refractory focal epilepsy…